Two Sigma Investments, LP Oncorus, Inc. Transaction History

Two Sigma Investments, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.28 - $0.45 $3,111 - $5,000	-11,112 Reduced 17.7%	51,680 $17,000
Q4 2022 Feb 14, 2023	SELL	$0.24 - $0.76 $4,488 - $14,212	-18,700 Reduced 22.95%	62,792 $15,000
Q3 2022 Nov 14, 2022	SELL	$0.85 - $1.65 $16,575 - $32,175	-19,500 Reduced 19.31%	81,492 $69,000
Q2 2022 Aug 15, 2022	SELL	$1.04 - $1.86 $54,739 - $97,899	-52,634 Reduced 34.26%	100,992 $127,000
Q1 2022 May 16, 2022	BUY	$1.44 - $5.62 $92,027 - $359,162	63,908 Added 71.23%	153,626 $273,000
Q4 2021 Feb 14, 2022	BUY	$5.03 - $11.63 $296,593 - $685,762	58,965 Added 191.74%	89,718 $473,000
Q3 2021 Nov 15, 2021	BUY	$9.29 - $14.27 $285,695 - $438,845	30,753 New	30,753 $287,000
Q2 2021 Aug 16, 2021	SELL	$13.3 - $17.3 $417,686 - $543,306	-31,405 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$11.89 - $35.55 $373,405 - $1.12 Million	31,405 New	31,405 $437,000

Ticker ONCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,973,100
Description
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.